(Q36718468)

English

An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults

scientific article published on April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

An open-label investigation of the pharmacokinetic profiles of lisdexamfetamine dimesylate and venlafaxine extended-release, administered alone and in combination, in healthy adults (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1

object named as

James Ermer

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

2

object named as

Mary B Haffey

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jaideep Purkayastha

6

object named as

Jaideep Purkayastha

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Cynthia Richards

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kenneth Lasseter

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Benno Roesch

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Mary Corcoran

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Bree Harlin

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Patrick Martin

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2013

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

243-254

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

copyright license

Creative Commons Attribution-NonCommercial 2.5 Generic

20 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

Atypical antipsychotic metabolism and excretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical trial in adults with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

30 September 2017

Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

28 June 2018

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

5 September 2018

An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608883

5 September 2018

Medication Adherence and Symptom Reduction in Adults Treated with Mixed Amphetamine Salts in a Randomized Crossover Study

1 reference

https://api.crossref.org/works/10.1007%2FS40261-013-0073-1

21 January 2018

Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/23512639

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40261-013-0073-1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36718468&oldid=2143367351"